7UX-61818-23489
2 vaccinations
2 coded responses
5 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 234 / VA
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-30
Dose 1 — Pfizer-BioNTech
-
2021-08-11
Registered in v-safe
-
2021-08-11
Survey response — day 7, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: The pain at injection site was in the days immediately after receiving the vaccine, none currently.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-15
-
2021-08-20
Dose 2 — Pfizer-BioNTech
- 2021-08-21
- 2021-08-22
-
2022-08-22
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: COVID positive in MayMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
Free text
Release 9 — day 7, dose 1
Systemic reaction (other): The pain at injection site was in the days immediately after receiving the vaccine, none currently.
Release 12 — 12 months, dose 2
Symptoms: COVID positive in May
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Injection site pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release